Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
Lung Cancer Session with leading UK thoracic experts David Baldwin, Beth Sage, Phillip Crosbie, Matthew Callister and Arjun Nair
CT screening for patients with lung cancer in the UK
In the third roundtable in a series of Lung Cancer Sessions organized by VJOncology and the British Thoracic Oncology Group (BTOG), leading UK thoracic experts David Baldwin, Beth Sage, Phillip Crosbie, Matthew Callister and Arjun Nair discuss CT screening for patients with lung cancer in the UK.
Part 1: The ACE programme and developing national screening
‘We’d had that really robust evidence there. It was not borderline. It showed us a clear message that lung cancer screening absolutely can be transformative.’
Phillip Crosbie
Part 2: The Targeted Lung Health Check programme & pilot studies
‘It’s great the way that the projects are working together to disseminate good ideas that have been shown to work in practice so that they just get rolled very quickly.’
Matthew Callister
Part 3: Lung cancer screening in Scotland
‘We don’t have a high turnover of GPs within practices, so they get to know families very well, and there’s a real trust built up between the patient and the GP. A lot of remote and rural GPs are incredibly enthusiastic and supportive of the programme’
Beth Sage
Part 4: Quality assurance in lung cancer screening
‘One of the most important things is agreeing the metrics, but also accepting that they have to be agile enough to adapt to the new changes. Because unfortunately, lung cancer screening is such a rapidly moving animal’
Arjun Nair
Part 5: The next steps in screening; AI, and adequate funding
‘As the TLHC programme expands, the gap in the UK between the other nations and England becomes even more dramatic, so there’s real need for political will from the other nations.’
Matthew Callister
‘Figures that came out recently showed early stage lung cancer diagnostic rating, in the whole population, has now moved up very considerably in the lowest socioeconomic quintile, so they’re actually at the top now.’
David Baldwin
The Lung Cancer Channel on VJOncology is supported by Takeda, Novocure and AstraZeneca.
These supporters have no influence over the production of the content.
July 2023
